CSL appoints Deborah Waterhouse as CEO & Managing Director
CSL Limited's board unanimously appointed Deborah Waterhouse as CEO & Managing Director effective 1 February 2027, concluding an extensive global search. Waterhouse has been CEO of ViiV Healthcare since 2017, the GSK-majority-owned HIV specialist with £7.7 billion in FY25 sales, and also serves as President of GSK Global Health. Gordon Naylor will continue as Interim CEO until 1 February 2027 and then return to the Board as a non-executive director, with a formal transition planned.
Key figures
- Start date
- 1 February 2027
- Base salary
- £1,500,000 per annum
- Extra psu award
- £1.65m
- Gsk award buyout
- £7.71m in RSUs
- Viiv sales fy2025
- £7.7 billion
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.